Journal of Dental Research, Vol 72, 517-523, Copyright © 1993 by International & American Associations for Dental Research Online Journals

ARTICLES

In vitro antimicrobial activity of the human neutrophil cytosolic S-100 protein complex, calprotectin, against Capnocytophaga sputigena

K. T. Miyasaki, A. L. Bodeau, A. R. Murthy and R. I. Lehrer
Section of Oral Biology, UCLA School of Dentistry 90024-1668.

Calprotectin is a complex of two anionic proteins found in abundance in the cytosol of neutrophils, certain macrophages, and oral epithelial keratinocytes. Bacteria of the genus Capnocytophaga are pathogens of periodontal origin which can cause systemic infection in neutropenic subjects. Recently, it has been observed that Capnocytophaga may be internalized by neutrophils within the cytosol rather than within a membrane-delimited phagosome. The purpose of this study was to test the in vitro antibacterial effect of the cytosolic complex, calprotectin, against Capnocytophaga sputigena. Calprotectin was purified from the cytosol of human neutrophils by gel filtration and anion exchange FPLC, and it exerted potent in vitro antimicrobial effects against C. sputigena. Net bacteriostatic activity was exerted up to 18 h, after which bactericidal effects were observed. Both net bacteriostatic and bactericidal activity occurred at concentrations above 20 micrograms/mL and exhibited identical dose-response characteristics. Particle counts increased in the presence of calprotectin, despite net bacteriostasis as assessed by changes in colony-forming units (CFU). Dose-response characteristics and direct particle counts suggested that net bacteriostatic effects were the result of balanced cell division and death, rather than suspension of cell division. We conclude that calprotectin can be a significant contributor to host defense against infection by Capnocytophaga.

This article has been cited by other articles:

				M.-A. Raquil, N. Anceriz, P. Rouleau, and P. A. Tessier Blockade of Antimicrobial Proteins S100A8 and S100A9 Inhibits Phagocyte Migration to the Alveoli in Streptococcal Pneumonia J. Immunol., March 1, 2008; 180(5): 3366 - 3374. [Abstract] [Full Text] [PDF]

				M. G. Gravett, M. J. Novy, R. G. Rosenfeld, A. P. Reddy, T. Jacob, M. Turner, A. McCormack, J. A. Lapidus, J. Hitti, D. A. Eschenbach, et al. Diagnosis of Intra-amniotic Infection by Proteomic Profiling and Identification of Novel Biomarkers JAMA, July 28, 2004; 292(4): 462 - 469. [Abstract] [Full Text] [PDF]

				K. Nisapakultorn, K. F. Ross, and M. C. Herzberg Calprotectin Expression In Vitro by Oral Epithelial Cells Confers Resistance to Infection by Porphyromonas gingivalis Infect. Immun., July 1, 2001; 69(7): 4242 - 4247. [Abstract] [Full Text] [PDF]

				A. Voganatsi, A. Panyutich, K. T. Miyasaki, and R. K. Murthy Mechanism of extracellular release of human neutrophil calprotectin complex J. Leukoc. Biol., July 1, 2001; 70(1): 130 - 134. [Abstract] [Full Text] [PDF]

				K. Nisapakultorn, K. F. Ross, and M. C. Herzberg Calprotectin Expression Inhibits Bacterial Binding to Mucosal Epithelial Cells Infect. Immun., June 1, 2001; 69(6): 3692 - 3696. [Abstract] [Full Text] [PDF]

				K. F. Ross and M. C. Herzberg Calprotectin Expression by Gingival Epithelial Cells Infect. Immun., May 1, 2001; 69(5): 3248 - 3254. [Abstract] [Full Text] [PDF]

				P. G. Sohnle and B. L. Hahn Effect of Zinc-Reversible Growth-Inhibitory Activity in Human Empyema Fluid on Antibiotic Microbicidal Activity Antimicrob. Agents Chemother., January 1, 2000; 44(1): 139 - 142. [Abstract] [Full Text]